Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-7.02 %
$ 6.79 M
Market Cap
-0.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
51.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adial Pharmaceuticals, Inc.
ADIL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ADIL
EBIT FORECAST
EBIT Forecast Chart ADIL
NET INCOME FORECAST
Net Income Chart ADIL